AGP Executive Report
Last update: 9 hours agoWound-care biotech in the Pacific Northwest: AGC Biologics will manufacture Flen Health’s next-gen wound and skin healing therapy (lactoperoxidase + glucose oxidase), moving into GMP process development and clinical-scale production ahead of an IND and Phase II trials. Local emergency care: A house fire in Seattle’s Matthews Beach area sent one occupant to Harborview and injured multiple firefighters after a deck/awning collapse; the cause is under investigation. Public health + family medicine trust: New research suggests how clinicians deliver “normal” test results—warmth and capability in tone—can shape whether patients feel reassured or push for more care. Community resilience via clean energy: Toppenish School District unveiled a $1.7M solar-plus-battery system at Valley View Elementary to cut energy costs and keep the school running during outages. Health policy + safety: Seattle’s mayoral budget plan shifts violence-prevention contracts toward a new department structure aimed at building performance metrics for community intervention groups. Cancer research pipeline: Aptevo says it’s advancing scalable manufacturing for a next-generation trispecific cancer candidate, targeting IND-enabling work in 1H2027.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
